NCT06858319 - Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy. | Biotech Hunter

Enrollment

223

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

June 25, 2031

Study Completion Date

June 25, 2031

Conditions

Kidney DiseasesKidney Diseases, ChronicUrological DiseasesGlomerulonephritisGlomerular DiseaseGlomerulonephritis, IGAGlomerulopathyImmunoglobulin Disease

Interventions

DRUG

zigakibart

solution for subcutaneous injection

Trial Locations (1)

80230

RECRUITING

Colorado Kidney Care Nephrology, Denver